China's medical enterprises in the supply chain there are operational efficiency is low, the market is small, the number of numerous, concentrated, low rate of agglomeration and other issues, and the supply chain of information between enterprises, capital, communication is not good, so that the supply chain of medicines in the long term there is a chaotic phenomenon, from the planning and purchasing, warehousing and storage, pharmacy drug receipt and dispensing and the treatment of adverse reactions of the patients after the use of medicines. In all aspects, drug supply management has a lot of defects.
Analysis of the current situation of the pharmaceutical supply chain
1, the channels of pharmaceutical circulation is chaotic, not easy to regulate
China's pharmaceutical circulation channel mainly involves pharmaceutical product manufacturers, wholesalers, retailers, patients and so on, on the surface of the appearance of only a few participating units, but, but it can be varied in a number of different models of the pharmaceutical supply chain. For example, pharmaceutical manufacturer-wholesaler-retailer-patient. Then there are pharmaceutical manufacturer-retailer-patient. Some will omit some of the links. These different channels make it more difficult for regulators to supervise, and also create certain obstacles for the convenience of patients themselves.
2, the supply chain involves many aspects of the current pharmaceutical supply chain, from raw material suppliers, drug manufacturers to wholesalers, and then retailers, and ultimately to hospitals or pharmacies. On the one hand, the price is not uniform, on the other hand, there are hidden problems in product supply, quality assurance, etc. 3, high cost of pharmaceutical supply chain
From the raw materials into the production plant to the made of medicines, the cost of this intermediate cost is very low, but drugs in the process of reaching the hands of the patient in the process of the circulation costs can account for a large part of the total cost. Although pharmaceutical manufacturers and wholesalers and retailers at all levels do not appear to have suffered any losses on the surface, patients' resistance to high drug prices indirectly affects the interests of pharmaceutical manufacturers and distributors at all levels, in a hidden sense.
The current problems in the pharmaceutical supply chain
1, inventory problems In the procurement model of the pharmaceutical supply, wholesalers and retailers at all levels are based on their own market understanding of the situation to determine their own inventory, there is no formation of an orderly and efficient inventory model. And each other due to the lack of effective information **** enjoy, it is difficult to achieve an effective allocation of pharmaceutical resources.
2, the risk problem
Since it involves a lot of wholesalers and retailers, there are differences in transportation conditions and storage equipment, which makes it difficult to ensure that the same products still maintain the same quality after leaving the factory. Pharmaceuticals, as a special product that is important to the lives of patients, are subject to high quality requirements. Because of the increased difficulty of regulation, the risk factor of pharmaceuticals before they reach the hands of patients has been increased again and again.
3, procurement costs
In the multilevel wholesalers, sporadic distribution of pharmacies and hospital pharmacies, due to "their own way", each other's information does not **** to enjoy and other reasons, coupled with the process of procurement of medicines, manufacturers, suppliers need to carry out the necessary negotiation, formalities, etc., all make the Pharmaceutical logistics costs have increased, which in turn affects procurement costs.
4, doctor-patient problem
Drugs as special consumer goods, when it comes to economic interests, often unlawful behavior occurs. Doctors, as professional masters of technical knowledge, can take advantage of this advantage to maximize their own interests, and thus in prescribing medicines to patients, there are often abuses of antibiotics, the use of expensive alternative medicines and other phenomena, which cause physical pain not to mention the patients, but also cause financial losses.
The development trend of the pharmaceutical supply chain In the context of the domestic pharmaceutical reform, the future of pharmaceutical commercial companies may be the distribution company + information company + financing company, in the new policy and market environment, the logistics positioning the more clear and precise, the strategic landing in order to be more rapid and powerful.
1. Logistics concentration, specialization and further enhancement Due to the implementation of the "two-ticket system" drug manufacturers need to directly face the provincial and even municipal commercial companies, management difficulties increase, so manufacturers are more willing to choose to cooperate with a strong group of commercial companies, resulting in a number of small and medium-sized pharmaceutical companies to exit the market or join the group of commercial enterprises. As a result, many small and medium-sized pharmaceutical enterprises will withdraw from the market or join the group commercial enterprises, thus the concentration of the industry will be greatly increased, which will promote the supply chain and efficient synergy, and strive for more market share. With the promotion of the "two-invoice system", circulation enterprises should take the initiative to provide better services and convenience for upstream production enterprises, and promote efficient synergy in the supply chain. 2. Logistics network operation National pharmaceutical policy, the market environment has put forward more requirements for pharmaceutical logistics, such as the expansion of the sales scale of the challenge of the warehouse capacity; drug supervision departments across the country on the quality of pharmaceutical warehousing and distribution to put forward higher requirements; zero-differential rate of drugs, upstream and downstream terminals will be further compression of the profits of the pharmaceutical distribution enterprises, forcing the enterprise to further improve the efficiency of the use of funds; more and more peripheral competitors into the pharmaceutical business, in order to ensure the supply of medicines on the basis of the distribution of pharmaceuticals. Business, in order to ensure the supply of medicine on the basis of higher requirements for the efficiency of drug distribution and so on. With the changes in the market and policy, the flattening of the logistics network and the integration of multiple warehouses is the general trend.
3. Transformation of the functions of pharmaceutical companies from the relationship maintenance, channel development, policy to fight, advances, collection, logistics and distribution, gradually to marketing services, pharmacy management, health services, logistics and professional distribution, etc. Transformation of the customer-centered service consciousness, the concept will gradually strengthen the industry's overall level of service will be significantly improved. For the relatively closed, conservative pharmaceutical distribution industry, although the pharmaceutical logistics has its particularity and professionalism, but with the gradual improvement of social logistics capabilities, pharmaceutical companies need to be more open, **** enjoy, inclusive mentality to actively integrate into the large social professional logistics system, the use of social resources, joint ventures and other ways, only in this way can reduce logistics costs and improve logistics service capabilities. Such as SF through the acquisition of a GSP-qualified enterprises in Sichuan, Guangdong, the construction of modern pharmaceutical logistics centers, trying to enter the pharmaceutical logistics industry.
4. Logistics automation and modernization to enhance the level of At present, in addition to several large-scale pharmaceutical business enterprises logistics network, scale, capacity, information technology level is better, the industry's overall logistics status and ability is not optimistic, there is a general lack of awareness of the core competitiveness of logistics, the lack of attention to the situation. Accompanied by decentralization, the impact of the Internet experience economy, logistics information technology, especially the mobile Internet, big data, cloud computing and other technology application level will be greatly enhanced, the industry's development will be fully dependent on information technology to achieve the logistics of the whole process of visualization, controllable, manageable and traceable.